Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis

20Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Idiopathic hypertrophic chronic pachymeningitis (IHCP) is characterised by inflammatory fibrotic thickening of the dura mater. Long term management is controversial. A 28 year old man with craniospinal IHCP and prominent lymphocytic meningitis is reported. Cerebrospinal fluid and histological examination suggested a CD4+ T cell driven process and B cell stimulation. After surgical, tuberculostatic, and immunosuppressive treatment failed to control the progressive meningeal hypertrophy, causing severe headache and neurological disability, the disease process eventually abated with intraventricular cytarabine treatment.

Cite

CITATION STYLE

APA

Kleiter, I., Hans, V. H., Schuierer, G., Marienhagen, J., Hau, P., Schütz, H., … Steinbrecher, A. (2004). Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis. Journal of Neurology, Neurosurgery and Psychiatry, 75(9), 1346–1348. https://doi.org/10.1136/jnnp.2003.024653

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free